Cargando…

Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease

Neutrophils have been found to play an important role in the pathogenesis of inflammatory bowel disease (IBD), and anti-TNF-α mAb (i.e., infliximab) therapy is demonstrated to be effective in the induction of clinical remission and mucosal healing in these patients. However, how anti-TNF-α mAb regul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Cui, Shu, Weigang, Zhou, Guangxi, Lin, Jian, Chu, Feifei, Wu, Huili, Liu, Zhanju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282128/ https://www.ncbi.nlm.nih.gov/pubmed/30595666 http://dx.doi.org/10.1155/2018/3021863

Ejemplares similares

Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease
por: Zhou, Guangxi, et al.
Publicado: (2016)

Anti-TNF-α Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease
por: Shu, Weigang, et al.
Publicado: (2019)

Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease
por: Li, Gengfeng, et al.
Publicado: (2021)

Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
por: Lo, Wing-Cheong, et al.
Publicado: (2016)

Correction: Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
Publicado: (2017)

Interplay of intestinal microbiota and mucosal immunity in inflammatory bowel disease: a relationship of frenemies
por: Chen, Huimin, et al.
Publicado: (2020)

Dichotomous roles of neutrophils in modulating pathogenic and repair processes of inflammatory bowel diseases
por: Chen, Huimin, et al.
Publicado: (2021)

Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patients
por: Milanesi, Elena, et al.
Publicado: (2019)

Food-specific IgGs Are Highly Increased in the Sera of Patients with Inflammatory Bowel Disease and Are Clinically Relevant to the Pathogenesis
por: Xiao, Nanping, et al.
Publicado: (2018)

Rate and Predictors of Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Anti-TNF-Alpha Antibodies
por: Beigel, Florian, et al.
Publicado: (2014)

Internalization of Neutrophil-Derived Microvesicles Modulates TNFα-Stimulated Proinflammatory Cytokine Production in Human Fibroblast-Like Synoviocytes
por: Zhan, Dong, et al.
Publicado: (2021)

Monocyte Chemotactic Protein 1-Induced Protein 1 Is Highly Expressed in Inflammatory Bowel Disease and Negatively Regulates Neutrophil Activities
por: Lin, Jian, et al.
Publicado: (2020)

Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease
por: Lin, Ritian, et al.
Publicado: (2018)

A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-α therapy
por: Chebli, Júlio Maria Fonseca, et al.
Publicado: (2014)

IgA Nephropathy in the Setting of Anti-TNF-α Therapy for Inflammatory Bowel Disease
por: Strobel, Thomas, et al.
Publicado: (2020)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)

Neutrophils produce proinflammatory or anti-inflammatory extracellular vesicles depending on the environmental conditions
por: Kolonics, Ferenc, et al.
Publicado: (2021)

Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
por: Mihai, Ioana Ruxandra, et al.
Publicado: (2023)

A systems biology approach to suppress TNF-induced proinflammatory gene expressions
por: Hayashi, Kentaro, et al.
Publicado: (2013)

Erratum: Transmembrane TNF-α Density, But Not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)

Intestinal epithelial pH-sensing receptor GPR65 maintains mucosal homeostasis via regulating antimicrobial defense and restrains gut inflammation in inflammatory bowel disease
por: Li, Gengfeng, et al.
Publicado: (2023)

Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
por: Mitselou, Antigony, et al.
Publicado: (2020)

Proinflammatory cytokines IL-6 and TNF-α and the development of inflammation in obese subjects
por: Popko, K, et al.
Publicado: (2010)

Exosomes secreted by Blastocystis subtypes affect the expression of proinflammatory and anti-inflammatory cytokines (TNFα, IL-6, IL-10, IL-4)
por: Norouzi, Mojtaba, et al.
Publicado: (2022)

Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study
por: Marin-Jimenez, Ignacio, et al.
Publicado: (2020)

Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
por: Park, Jihye, et al.
Publicado: (2022)

Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel disease
por: Schultheiss, Johannes P. D., et al.
Publicado: (2021)

Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines
por: CHOO, BYUNG KIL, et al.
Publicado: (2013)

Human vascular endothelial cells produce TNF-α after stimulation with proinflammatory cytokines
por: Ranta, V, et al.
Publicado: (1999)

Anti‐TNF‐induced lupus in patients with inflammatory bowel disease
por: Picardo, Sherman, et al.
Publicado: (2019)

Suppressive Effects of a Truncated Inhibitor K562 Protein-Derived Peptide on Two Proinflammatory Cytokines, IL-17 and TNF-α
por: Hwang, Jong Tae, et al.
Publicado: (2020)

FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents
por: Guidi, Luisa, et al.
Publicado: (2013)

Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome
por: Trbojević Akmačić, Irena, et al.
Publicado: (2015)

The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases
por: Li, Yichen, et al.
Publicado: (2022)

Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing
por: Song, Yijie, et al.
Publicado: (2022)

Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti‐TNF therapy in a tuberculosis endemic region
por: Ye, Lingna, et al.
Publicado: (2020)

Potential Role of NK Cells in the Pathogenesis of Inflammatory Bowel Disease
por: Yadav, Praveen K., et al.
Publicado: (2011)

Suppression of endothelial cell activity by inhibition of TNFα
por: Shu, Qiang, et al.
Publicado: (2012)

Proinflammatory cytokine TNFα promotes HPV-associated oral carcinogenesis by increasing cancer stemness
por: Hong, Hannah S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_drftqpc8iug6plhdgfreubevkj